STXS
Price:
$1.94
Market Cap:
$164.23M
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, inc...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2004-08-12
Stock Exchange
AMEX
Ticker
STXS
According to Stereotaxis, Inc.’s latest financial reports and current stock price. The company's current ROE is -101.61%. This represents a change of 291.65% compared to the average of -25.94% of the last 4 quarters.
The mean historical ROE of Stereotaxis, Inc. over the last ten years is -5.94%. The current -101.61% ROE has changed 1.61% with respect to the historical average. Over the past ten years (40 quarters), STXS's ROE was at its highest in in the September 2016 quarter at 28.95%. The ROE was at its lowest in in the March 2019 quarter at -39.84%.
Average
-5.94%
Median
-6.62%
Minimum
-94.49%
Maximum
41.72%
Discovering the peaks and valleys of Stereotaxis, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 180.27%
Maximum Annual ROE = 41.72%
Minimum Annual Increase = -1024.23%
Minimum Annual ROE = -94.49%
Year | ROE | Change |
---|---|---|
2023 | -94.49% | 57.54% |
2022 | -59.98% | 180.27% |
2021 | -21.40% | 33.42% |
2020 | -16.04% | 8.09% |
2019 | -14.84% | -1024.23% |
2018 | 1.61% | -94.38% |
2017 | 28.57% | -16.08% |
2016 | 34.04% | -18.39% |
2015 | 41.72% | 0.63% |
2014 | 41.45% | -92.94% |
The current ROE of Stereotaxis, Inc. (STXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-58.62%
5-year avg
-41.35%
10-year avg
-5.94%
Stereotaxis, Inc.’s ROE is greater than Accuray Incorporated (-33.65%), greater than AngioDynamics, Inc. (-95.11%), less than Cutera, Inc. (78.70%), greater than AtriCure, Inc. (-8.42%), greater than EDAP TMS S.A. (-36.00%),
Company | ROE | Market cap |
---|---|---|
-33.65% | $180.49M | |
-95.11% | $273.88M | |
78.70% | $11.23M | |
-8.42% | $1.64B | |
-36.00% | $99.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Stereotaxis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Stereotaxis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Stereotaxis, Inc.'s ROE?
How is the ROE calculated for Stereotaxis, Inc. (STXS)?
What is the highest ROE for Stereotaxis, Inc. (STXS)?
What is the 3-year average ROE for Stereotaxis, Inc. (STXS)?
What is the 5-year average ROE for Stereotaxis, Inc. (STXS)?
How does the current ROE for Stereotaxis, Inc. (STXS) compare to its historical average?